» Articles » PMID: 34732122

In Vitro Antitumor Evaluation of Acrylic Acid Derivatives Bearing Quinolinone Moiety As Novel Anticancer Agents

Overview
Specialties Chemistry
Oncology
Date 2021 Nov 4
PMID 34732122
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Due to the emergence of resistance to available anticancer agents, the demand for new cytotoxic agents has grown.

Objective: This study aims at synthesis and cytotoxic evaluation of new acrylic acid derivatives bearing quinolinone and halogenated quinolinone derivatives against three cancer cell lines.

Methods: New acrylic acid derivatives bearing quinolinone and halogenated quinolinone moieties were synthesized and screened for their cytotoxic activity against breast MCF-7, liver HepG2, and colon HCT-116 cancer cell lines.

Results: Molecules 3 and 8 showed the most potent cytotoxic activity against HCT-116. DNA flow cytometry assay showed cell cycle arrest at the G1 phase and cellular apoptosis. Moreover, molecules 3 and 8 showed cyclin-dependent kinase 2 (CDK2) inhibitory activity compared to the untreated control sample.

Conclusion: Acrylic acid derivatives bearing quinolinone and halogenated quinolinone moieties represent an important core and could be used as a lead for further development of drug compounds in order to achieve promising therapeutic results.

Citing Articles

Molecular Docking and In Vivo Biological Studies of Sodium Salt of 3-(4-Methyl-2-oxo-2-H-quinoline-7-yloxy)-3-phenylacrylic Acid As Anticancer Agent.

Mohamed F, Eid S, Elghareb M, Abas A Dokl Biochem Biophys. 2023; 512(1):300-318.

PMID: 38093135 DOI: 10.1134/S1607672923600203.


Design, synthesis and antiproliferative screening of newly synthesized coumarin-acrylamide hybrids as potential cytotoxic and apoptosis inducing agents.

Abd El-Lateef H, Abdel Ghany L, Saleem R, Ahmed Maghrabi A, Yahya Alahdal M, Khalifa Ali E RSC Adv. 2023; 13(46):32547-32557.

PMID: 37936638 PMC: 10626558. DOI: 10.1039/d3ra06644d.


Design, synthesis and antiproliferative screening of newly synthesized acrylate derivatives as potential anticancer agents.

Alshaya D, Tawakul R, Zaki I, Almaaty A, Fayad E, Abd El-Aziz Y RSC Adv. 2023; 13(34):23538-23546.

PMID: 37546218 PMC: 10402871. DOI: 10.1039/d3ra03849a.